Cingulate Inc. (NasdaqCM: CING)
Health Care · Pharmaceuticals · US
$4.85
-0.82% today · +20.7% 1Y
Cingulate Inc. (NasdaqCM: CING) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $71.11M and employs 14 people.
Over the last twelve months the share price has gained 20.7%, trading between 3.16 and 11.89.
Tweenvest scores Cingulate Inc. across four factors: quality 37/100, value 75/100. Its strongest factor is value.
CING price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $71.11M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -3.28
- Dividend yield
- —
- Beta (5Y)
- -0.88
- 52-week high
- $11.89
- 52-week low
- $3.16
- Avg volume (3M)
- —
- Shares outstanding
- 14.54M
- Employees
- 14
- Next earnings
- —
About Cingulate Inc.
Cingulate Inc. is a biopharmaceutical enterprise currently in its clinical development phase, dedicated to devising therapeutic options for attention-deficit/hyperactivity disorder (ADHD). Leading its pipeline for ADHD are two drug candidates: CTx-1301 (dexmethylphenidate), which is currently progressing through Phase 3 clinical trials, and CTx-1302 (dextroamphetamine). The company is also engaged in the advancement of CTx-2103, a candidate intended for the management of anxiety disorders. Founded in 2012, Cingulate Inc. maintains its corporate headquarters in Kansas City, Kansas.
- ISIN
- US17248W3034
- Founded
- 2012
- Listed since
- Dec 8, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Techlead Next Public Company LimitedSET: TL-R | $73.04M | ฿0.43 | -4.44% |
| Charlotte's Web Holdings, Inc.TSX: CWEB | $72.25M | CA$0.38 | 0.00% |
| PhytoHealth CorporationTWSE: 4108 | $71.75M | NT$11.55 | +1.76% |
| Domesco Medical Import - Export Joint-Stock CorporationHOSE: DMC | $71.51M | ₫53,300.00 | -2.74% |
| Cantourage Group SEXTRA: HIGH | $70.93M | €4.98 | -1.97% |
| Bangkok Lab And Cosmetic Public Company LimitedSET: BLC | $70.81M | ฿3.96 | +0.51% |
| Wanbury LimitedBSE: 524212 | $70.71M | Rs195.85 | -1.58% |
| DongKoo Bio & Pharma Co., Ltd.KOSDAQ: A006620 | $70.70M | ₩3,515.00 | -0.14% |
Figures last refreshed Oct 11, 2026.